Raoul Herbrecht
#153,491
Most Influential Person Now
French hematologist
Raoul Herbrecht's AcademicInfluence.com Rankings
Raoul Herbrechtmedical Degrees
Medical
#2974
World Rank
#3422
Historical Rank
Hematology
#45
World Rank
#51
Historical Rank
Raoul Herbrechtphilosophy Degrees
Philosophy
#8580
World Rank
#11989
Historical Rank
Logic
#5613
World Rank
#7024
Historical Rank
Download Badge
Medical Philosophy
Raoul Herbrecht's Degrees
- Doctorate Medicine Université Paris Cité
- PhD Hematology University of Strasbourg
Why Is Raoul Herbrecht Influential?
(Suggest an Edit or Addition)Raoul Herbrecht's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. (2008) (4348)
- Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. (2002) (3019)
- CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. (2002) (2551)
- Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. (2008) (2526)
- Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016) (1683)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients. (2012) (1017)
- Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. (2002) (840)
- Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline. (2018) (801)
- Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trial. (2007) (725)
- Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma. (2009) (621)
- Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial (2016) (600)
- Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial). (2007) (598)
- Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. (2007) (544)
- Posaconazole as Salvage Therapy for Zygomycosis (2006) (503)
- European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update (2011) (474)
- Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis. (2016) (467)
- Phase III randomized study of bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukemia. (2009) (460)
- ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients (2016) (424)
- International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. (1997) (422)
- A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients (1997) (409)
- Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. (2006) (400)
- Aspergillus galactomannan detection in the diagnosis of invasive aspergillosis in cancer patients. (2002) (399)
- Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. (2008) (355)
- Intensive conventional chemotherapy (ACVBP regimen) compared with standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma. (2003) (343)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures. (2012) (343)
- Factors associated with overall and attributable mortality in invasive aspergillosis. (2008) (320)
- Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. (2006) (311)
- Liposomal amphotericin B compared with amphotericin B deoxycholate in the treatment of documented and suspected neutropenia‐associated invasive fungal infections (1998) (309)
- Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3) (2013) (295)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: adults with haematological malignancies and after haematopoietic stem cell transplantation (HCT). (2012) (280)
- LNH-84 regimen: a multicenter study of intensive chemotherapy in 737 patients with aggressive malignant lymphoma. (1989) (270)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp. (2012) (267)
- An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: diagnosis and therapeutic outcome. EORTC Invasive Fungal Infections Cooperative Group. (1998) (265)
- Executive Summary: Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. (2016) (257)
- Combination Antifungal Therapy for Invasive Aspergillosis (2015) (244)
- Prognostic factors in aggressive malignant lymphomas: description and validation of a prognostic index that could identify patients requiring a more intensive therapy. The Groupe d'Etudes des Lymphomes Agressifs. (1991) (239)
- Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin's lymphoma in first complete remission: a study of 464 patients. Groupe d'Etude des Lymphomes de l'Adulte. (1994) (207)
- Multicenter, noncomparative study of caspofungin in combination with other antifungals as salvage therapy in adults with invasive aspergillosis (2006) (205)
- A Multicenter, double-blind trial of a high-dose caspofungin treatment regimen versus a standard caspofungin treatment regimen for adult patients with invasive candidiasis. (2009) (201)
- Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. (2003) (200)
- Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients. (2011) (196)
- Caspofungin: the first representative of a new antifungal class. (2003) (190)
- A systematic review of the antifungal effectiveness and tolerability of amphotericin B formulations. (2003) (180)
- Prognostic significance of received relative dose intensity in non-Hodgkin's lymphoma patients: application to LNH-87 protocol. The GELA. (Groupe d'Etude des Lymphomes de l'Adulte). (1993) (180)
- Forty-one recent cases of invasive zygomycosis from a global clinical registry. (2009) (177)
- Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts. (2007) (167)
- International Retrospective Analysis of 73 Cases of Invasive Fusariosis Treated with Voriconazole (2010) (163)
- Early diagnosis and monitoring of mucormycosis by detection of circulating DNA in serum: retrospective analysis of 44 cases collected through the French Surveillance Network of Invasive Fungal Infections (RESSIF). (2016) (158)
- Improvement in the outcome of invasive fusariosis in the last decade. (2014) (151)
- Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study (2010) (150)
- An EORTC Phase II study of caspofungin as first-line therapy of invasive aspergillosis in haematological patients. (2009) (149)
- Clinical pharmacokinetics of voriconazole. (2006) (147)
- The safety and efficacy of amphotericin B colloidal dispersion in the treatment of invasive mycoses. (1995) (140)
- Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies (2007) (136)
- Posaconazole: a potent, extended‐spectrum triazole anti‐fungal for the treatment of serious fungal infections (2004) (136)
- Treatment of 21 Cases of Invasive Mucormycosis with Amphotericin B Colloidal Dispersion (2001) (134)
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA) (2021) (126)
- Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization (2006) (125)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases. (2012) (123)
- Prognostic factors for death due to invasive aspergillosis after hematopoietic stem cell transplantation: a 1-year retrospective study of consecutive patients at French transplantation centers. (2006) (122)
- Epidemiology and risk factors for gram-positive coccal infections in neutropenia: toward a more targeted antibiotic strategy. (2003) (120)
- Amphotericin B and its new formulations: pharmacologic characteristics, clinical efficacy, and tolerability (1999) (119)
- Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d'Etude des Lymphomes Agressifs. (1991) (118)
- Risk stratification for invasive aspergillosis in immunocompromised patients (2012) (117)
- Bendamustine compared with chlorambucil in previously untreated patients with chronic lymphocytic leukaemia: updated results of a randomized phase III trial (2012) (113)
- The Enzymatic Basis of Drug-Drug Interactions with Systemic Triazole Antifungals (2008) (111)
- Voriconazole for invasive bone aspergillosis: a worldwide experience of 20 cases. (2005) (111)
- Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis. (2015) (111)
- Isavuconazole Versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial. (2018) (109)
- Bone marrow transplantation prolongs survival after relapse in aggressive-lymphoma patients treated with the LNH-84 regimen. (1992) (109)
- ECIL guidelines for the prevention, diagnosis and treatment of BK polyomavirus-associated haemorrhagic cystitis in haematopoietic stem cell transplant recipients (2017) (108)
- Towards novel paradigms for cancer therapy (2011) (108)
- Voriconazole: therapeutic review of a new azole antifungal (2004) (104)
- Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. (2001) (103)
- Bing-Neel syndrome, a rare complication of Waldenström macroglobulinemia: analysis of 44 cases and review of the literature. A study on behalf of the French Innovative Leukemia Organization (FILO). (2015) (101)
- Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. (1997) (100)
- Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome. (2005) (96)
- Placebo-controlled phase III study of lenograstim (glycosylated recombinant human granulocyte colony-stimulating factor) in aggressive non-Hodgkin's lymphoma: factors influencing chemotherapy administration. Groupe d'Etude des Lymphomes de l'Adulte. (1997) (96)
- Combined antifungal approach for the treatment of invasive mucormycosis in patients with hematologic diseases: a report from the SEIFEM and FUNGISCOPE registries (2013) (95)
- ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS. (2012) (89)
- A retrospective series of gut aspergillosis in haematology patients. (2011) (89)
- Changes in causes of death over time after treatment for invasive aspergillosis (2008) (84)
- Association of mannose-binding lectin deficiency with acute invasive aspergillosis in immunocompromised patients. (2009) (83)
- Survival impact of rituximab combined with ACVBP and upfront consolidation autotransplantation in high-risk diffuse large B-cell lymphoma for GELA (2011) (81)
- Value of autologous bone marrow transplantation in follicular lymphoma: a France Autogreffe retrospective study of 42 patients. (1994) (80)
- Saccharomyces cerevisiae fungemia: an adverse effect of Saccharomyces boulardii probiotic administration. (2005) (78)
- Treatment of invasive Candida and invasive Aspergillus infections in adult haematological patients (2007) (77)
- Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® (2019) (75)
- Early Serum Galactomannan Trend as a Predictor of Outcome of Invasive Aspergillosis (2012) (71)
- European expert opinion on the management of invasive candidiasis in adults. (2011) (71)
- Randomized comparison of ACVBP and m-BACOD in the treatment of patients with low-risk aggressive lymphoma: the LNH87-1 study. Groupe d'Etudes des Lymphomes de l'Adulte. (2000) (69)
- Computer tomography in pulmonary invasive aspergillosis in hematological patients with neutropenia: an useful tool for diagnosis and assessment of outcome in clinical trials. (2010) (67)
- Breakthrough invasive mould infections in patients treated with caspofungin. (2012) (67)
- Results of initial doxorubicin, 5‐fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast (1990) (67)
- Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. (2004) (66)
- Rituximab versus observation after high-dose consolidative first-line chemotherapy with autologous stem-cell transplantation in patients with poor-risk diffuse large B-cell lymphoma. (2009) (66)
- Adherence to recommendations for the use of antifungal agents in a tertiary care hospital. (2012) (66)
- Mucormycosis after allogeneic haematopoietic stem cell transplantation: a French Multicentre Cohort Study (2003-2008). (2012) (65)
- Efficacy of Amphotericin B Lipid Complex in the Treatment of Invasive Fungal Infections in Immunosuppressed Paediatric Patients (2001) (63)
- Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. (2003) (62)
- Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia. (2013) (60)
- Trichosporon infections: clinical manifestations and treatment (1993) (60)
- Impact of clinical pharmacy services in a hematology/oncology inpatient setting. (2015) (60)
- Biclonal and biallelic deletions occur in 20% of B-ALL cases with IKZF1 mutations (2013) (59)
- Drug-drug interactions of triazole antifungal agents in multimorbid patients and implications for patient care. (2009) (59)
- Invasive aspergillosis as an opportunistic infection in nonallografted patients with multiple myeloma: a European Organization for Research and Treatment of Cancer/ Invasive Fungal Infections Cooperative Group and the Intergroupe Français du Myélome. (2000) (58)
- Disseminated Trichosporon mycotoxinivorans, Aspergillus fumigatus, and Scedosporium apiospermum Coinfection after Lung and Liver Transplantation in a Cystic Fibrosis Patient (2012) (57)
- Proteomic analysis of malignant B-cell derived microparticles reveals CD148 as a potentially useful antigenic biomarker for mantle cell lymphoma diagnosis. (2009) (57)
- The lipid formulations of amphotericin B (2003) (57)
- Bendamustine Versus Chlorambucil in Treatment-Naive Patients with B-Cell Chronic Lymphocytic Leukemia (B-CLL): Results of an International Phase III Study. (2007) (56)
- Magnetic Resonance Imaging of Cerebral Aspergillosis: Imaging and Pathological Correlations (2016) (56)
- Progression-Free Survival as a Surrogate End Point for Overall Survival in First-Line Diffuse Large B-Cell Lymphoma: An Individual Patient-Level Analysis of Multiple Randomized Trials (SEAL). (2018) (54)
- Early proinflammatory cytokines and C‐reactive protein trends as predictors of outcome in invasive Aspergillosis. (2010) (54)
- Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B (2002) (51)
- HDAC inhibitors induce apoptosis in glucocorticoid-resistant acute lymphatic leukemia cells despite a switch from the extrinsic to the intrinsic death pathway. (2007) (50)
- Delayed elimination of methotrexate associated with co-administration of proton pump inhibitors. (2010) (49)
- Comparison of pixantrone-based regimen (CPOP-R) with doxorubicin-based therapy (CHOP-R) for treatment of diffuse large B-cell lymphoma. (2013) (49)
- Long‐term survival in post‐transplant lymphoproliferative disorders with a dose‐adjusted ACVBP regimen (2006) (48)
- Combination of caspofungin and an azole or an amphotericin B formulation in invasive fungal infections. (2006) (47)
- Progression-free survival at 24 months (PFS24) and subsequent outcome for patients with diffuse large B-cell lymphoma (DLBCL) enrolled on randomized clinical trials (2018) (46)
- Combination of recombinant interferon alpha‐2A and vinblastine in advanced renal cell cancer (1988) (45)
- Pharmacokinetic drug–drug interactions with methotrexate in oncology (2011) (45)
- Efficacy outcomes in a randomised trial of liposomal amphotericin B based on revised EORTC/MSG 2008 definitions of invasive mould disease (2011) (44)
- Indications and outcomes of antifungal therapy in French patients with haematological conditions or recipients of haematopoietic stem cell transplantation. (2012) (44)
- Liposomal Nystatin in Patients with Invasive Aspergillosis Refractory to or Intolerant of Amphotericin B (2004) (44)
- Discovery and identification of potential biomarkers in a prospective study of chronic lymphoid malignancies using SELDI-TOF-MS. (2006) (44)
- 18F-FDG PET/CT for invasive fungal infection in immunocompromised patients (2018) (43)
- Successful Outcome of Treatment of a Disseminated Infection Due to Fusarium dimerum in a Leukemia Patient (2002) (43)
- Systematic review and mixed treatment comparison of randomized evidence for empirical, pre-emptive and directed treatment strategies for invasive mould disease. (2011) (42)
- Epidemiological study of invasive pulmonary aspergillosis in a haematology unit by molecular typing of environmental and patient isolates of Aspergillus fumigatus. (2005) (41)
- FungiScope™—Global Emerging Fungal Infection Registry (2017) (41)
- Management of systemic fungal infections: alternatives to itraconazole. (2005) (41)
- Bilberry extract (Antho 50) selectively induces redox-sensitive caspase 3-related apoptosis in chronic lymphocytic leukemia cells by targeting the Bcl-2/Bad pathway (2015) (40)
- Chronic disseminated Trichosporon asahii infection in a leukemic child. (2002) (38)
- Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system (2019) (37)
- Severe intoxication with methotrexate possibly associated with concomitant use of proton pump inhibitors. (2010) (37)
- Preventing invasive fungal disease in patients with haematological malignancies and the recipients of haematopoietic stem cell transplantation: practical aspects. (2013) (37)
- Aggressive lymphomas with renal involvement: a study of 48 patients treated with the LNH-84 and LNH-87 regimens. Groupe d'Etude des Lymphomes de l'Adulte. (1994) (37)
- Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019. (2020) (36)
- Invasive Pulmonary Aspergillosis (2004) (36)
- High Incidence but Low Burden of Coronaviruses and Preferential Associations between Respiratory Viruses (2013) (36)
- Longer‐term follow‐up and outcome by tumour cell proliferation rate (Ki‐67) in patients with relapsed/refractory mantle cell lymphoma treated with lenalidomide on MCL‐001(EMERGE) pivotal trial (2015) (35)
- Antifungal combination treatment: a future perspective. (2006) (35)
- An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis. (2004) (35)
- Risk factors for Gram-negative bacterial infections in febrile neutropenia. (2005) (34)
- Safety and Efficacy of Amphotericin B Colloidal Dispersion (1999) (33)
- A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm (2013) (32)
- Cyclophosphamide/mitoxantrone/melphalan (CMA) regimen prior to autologous bone marrow transplantation (ABMT) in metastatic breast cancer. (1996) (31)
- Antifungal Therapy: New and Evolving Therapies (2020) (31)
- Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry (2020) (31)
- Polycythemia vera transforming to acute myeloid leukemia and complex abnormalities including 9p homogeneously staining region with amplification of MLLT3, JMJD2C, JAK2, and SMARCA2. (2008) (30)
- Liposomal Amphotericin B (L-AMB) as Initial Therapy for Invasive Filamentous Fungal Infections (IFFI): A Randomized, Prospective Trial of a High Loading Regimen vs. Standard Dosing (AmBiLoad Trial). (2005) (29)
- Effect of granulocyte colony-stimulating factor administration in elderly patients with aggressive non-Hodgkin's lymphoma treated with a pirarubicin-combination chemotherapy regimen. Groupe d'Etudes des Lymphomes de l'Adulte. (1996) (29)
- Beta-D-glucan detection test: a step toward preemptive therapy for fungal infections in leukemic patients? (2008) (28)
- Phase III study of patients with relapsed, refractory mantle cell lymphoma treated with temsirolimus compared with investigator's choice therapy (2008) (27)
- Fungal Infections in Patients With Neutropenia (2000) (27)
- A unique proteomic profile on surface IgM ligation in unmutated chronic lymphocytic leukemia. (2011) (27)
- Is the small non-cleaved-cell lymphoma histologic subtype a poor prognostic factor in adult patients? A case-controlled analysis. The Groupe d'Etude des Lymphomes de l'Adulte. (1996) (27)
- Resource use and cost of treatment with voriconazole or conventional amphotericin B for invasive aspergillosis (2007) (27)
- Candida catenulata Fungemia in a Cancer Patient (1999) (26)
- Invasive infections due to Candida norvegensis and Candida inconspicua: report of 12 cases and review of the literature. (2013) (26)
- Isavuconazole: A new broad-spectrum azole. Part 1: In vitro activity. (2018) (26)
- Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma (2019) (26)
- Mycograb for the treatment of invasive candidiasis. (2006) (26)
- Randomised comparison of voriconazole and amphotericin B in primary therapy of invasive aspergillosis. (2002) (25)
- Phase I/II study of pixantrone in combination with cyclophosphamide, vincristine, and prednisone in patients with relapsed aggressive non-Hodgkin lymphoma (2011) (24)
- Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients. (2015) (24)
- Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials (2017) (24)
- Prospective study of bacteraemia in cancer patients. Results of a French multicentre study. (1998) (24)
- Stimulation of B-cell lymphoproliferations with CpG-oligonucleotide DSP30 plus IL-2 is more effective than with TPA to detect clonal abnormalities (2009) (23)
- Addition of Rituximab Improves Outcome of HIV Negative Patients with Burkitt Lymphoma Treated with the Lmba Protocol: Results of the Randomized Intergroup (GRAALL-Lysa) LMBA02 Protocol. (IGR sponsored LMBA02, NCT00180882) (2012) (23)
- Prospective study of bacteraemia in cancer patients (1998) (23)
- Disseminated Trichosporon capitatum infection in a patient with acute leukemia undergoing bone marrow transplantation. (1990) (23)
- Isavuconazole: A new broad-spectrum azole. Part 2: pharmacokinetics and clinical activity. (2018) (23)
- Cola beverage and delayed elimination of methotrexate. (2010) (22)
- Cytogenetic studies of a series of 43 consecutive secondary myelodysplastic syndromes/acute myeloid leukemias: conventional cytogenetics, FISH, and multiplex FISH. (2006) (22)
- A multivariate analysis of the survival of patients with aggressive lymphoma (1998) (22)
- Cell-surface expression of the TLR homolog CD180 in circulating cells from splenic and nodal marginal zone lymphomas (2013) (21)
- Matched-paired analysis of patients treated for invasive mucormycosis: standard treatment versus posaconazole new formulations (MoveOn). (2019) (21)
- Cost effectiveness of posaconazole in the prophylaxis of invasive fungal infections in acute leukaemia patients for the French healthcare system (2011) (21)
- An elevated pro-inflammatory cytokine response is linked to development of amphotericin B-induced nephrotoxicity. (2013) (21)
- Phase II Multicenter Study of Single-Agent Lenalidomide in Subjects with Mantle Cell Lymphoma Who Relapsed or Progressed After or Were Refractory to Bortezomib: The MCL-001 “EMERGE” Study (2012) (21)
- A multivariate analysis of the survival of patients with aggressive lymphoma: variations in the predictive value of prognostic factors during the course of the disease. Groupe d'Etudes des Lymphomes de l'Adulte. (1998) (21)
- The changing epidemiology of fungal infections: are the lipid‐based forms of amphotericin B an advance? (1996) (21)
- A multicentre pharmacoepidemiological study of therapeutic practices in invasive fungal infections in France during 1998-1999. (2004) (21)
- Post-traumatic intracranial epidural Aspergillus fumigatus abscess. (1997) (20)
- BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo (2019) (20)
- New pharmacological opportunities for the treatment of invasive mould diseases. (2017) (20)
- Interactions of cyclosporine with antimicrobial agents. (1990) (20)
- Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature. (2019) (19)
- Paralytic ileus possibly associated with interaction between ritonavir/lopinavir and vincristine (2009) (19)
- Treatment outcome of invasive mould disease after sequential exposure to azoles and liposomal amphotericin B. (2010) (19)
- Invasive pulmonary aspergillosis. (2004) (19)
- 18F-FDG PET/CT for the Diagnosis of Malignant and Infectious Complications After Solid Organ Transplantation (2017) (19)
- Tuberculosis and atypical mycobacterial infections in ruxolitinib-treated patients with primary or secondary myelofibrosis or polycythemia vera. (2019) (18)
- Voriconazole or Amphotericin B as Primary Therapy Yields Distinct Early Serum Galactomannan Trends Related to Outcomes in Invasive Aspergillosis (2014) (18)
- Simultaneous primary invasive cutaneous aspergillosis in two preterm twins: case report and review of the literature (2017) (17)
- [Piperacilline/tazobactam combination+amikacin versus ceftazidime+amikacin in patients with neutropenia and fever. An open multicenter study. Groupe d'étude des Aplasies Fébriles]. (1995) (17)
- 10 Years Follow-up of the GELA LNH98.5 Study, First Randomized Study Comparing R-CHOP to CHOP Chemotherapy in Patients with Diffuse Large B-Cell Lymphoma. (2009) (17)
- Idiosyncratic drug-induced neutropenia and agranulocytosis (2017) (17)
- Lessons from a Case of Oromandibular Mucormycosis Treated with Surgery and a Combination of Amphotericin B Lipid Formulation plus Caspofungin (2010) (17)
- Idiosyncratic drug-induced neutropenia & agranulocytosis. (2017) (17)
- Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis in Elderly Patients (≥75 years): A Monocentric Cohort Study of 61 Cases (2016) (16)
- Invasive aspergillosis in the hematologic and immunologic patient: new findings and key questions in leukemia. (2005) (16)
- Real‐world non‐interventional long‐term post‐authorisation safety study of ruxolitinib in myelofibrosis (2020) (15)
- Forum report: issues in the evaluation of diagnostic tests, use of historical controls, and merits of the current multicenter collaborative groups. (2003) (15)
- Randomised, multicentre trial of micafungin vs. an institutional standard regimen for salvage treatment of invasive aspergillosis (2015) (15)
- Isolated Renal Aspergillus Abscess in an AIDS Patient with a Normal CD4+ Cell Count on Highly Active Antiretroviral Therapy (1999) (15)
- Evaluation of Two Commercial Real-Time PCR Kits for Aspergillus DNA Detection in Bronchoalveolar Lavage Fluid in Patients with Invasive Pulmonary Aspergillosis (2018) (15)
- Needles in a haystack: Extremely rare invasive fungal infections reported in FungiScope® - Global Registry for Emerging Fungal Infections. (2020) (14)
- Cunninghamella bertholletiae: an uncommon agent of opportunistic fungal infection. Case report and review. (1991) (14)
- Outcome is not improved by the use of alternating chemotherapy in elderly patients with aggressive lymphoma. (2001) (14)
- Rituximab vs Observation after High-Dose Consolidative First-Line Chemotherapy (HDC) with Autologous Stem Cell Transplantation in Poor Risk Diffuse Large B-Cell Lymphoma. Final Analysis of the LNH98-B3 GELA Study. (2005) (13)
- 13q deletions in B-cell lymphoproliferative disorders: frequent association with translocation. (2007) (13)
- Diagnosis of IPA in HIV: the role of the chest X-ray and radiologist (2004) (13)
- Concomitant haemorrhagic syndrome and recurrent extensive arterial thrombosis in a patient with COVID‐19 and acute promyelocytic leukaemia (2020) (12)
- Emergence of unusual cytogenetic abnormalities under interferon-alpha therapy in patients with chronic myelogenous leukemia. (1999) (12)
- Characterization of efficacy and safety of pathogen inactivated and quarantine plasma in routine use for treatment of acquired immune thrombotic thrombocytopenic purpura (2018) (12)
- Safety and efficacy of Intralipid emulsions of amphotericin B. (1997) (12)
- Fungal Infections Caused by Kazachstania spp., Strasbourg, France, 2007–2020 (2022) (12)
- Safety of amphotericin B colloidal dispersion (2005) (11)
- Successful Treatment of a Granulocytic Sarcoma of the Uterine Cervix in Complete Remission at Six-Year Follow-Up (2010) (11)
- Fatal stimulation of acute myeloid leukemia blasts by pegfilgrastim. (2014) (11)
- Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature (2019) (11)
- Prognostic value of high-sensitivity measurable residual disease assessment after front-line chemoimmunotherapy in chronic lymphocytic leukemia (2020) (11)
- Safety and tolerability of combination anidulafungin (ANID) and liposomal amphotericn B (LAmB) for the treatment of invasive aspergillosis (IA) (2004) (11)
- Forum report: issues in the design of trials of drugs for the treatment of invasive aspergillosis. (2003) (10)
- Paclitaxel-anthracycline combination chemotherapy in relapsing advanced ovarian cancer after platinum-based chemotherapy: a pilot study. (1998) (10)
- Primary hepatic lymphoma associated with chronic hepatitis C. (1997) (10)
- Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers (2019) (10)
- Treatment outcomes in patients with proven/probable vs possible invasive mould disease in a phase III trial comparing isavuconazole vs voriconazole (2018) (9)
- Severe methotrexate toxicity due to a concomitant administration of ciprofloxacin. (2013) (9)
- Achievements and goals of the EORTC Invasive Fungal Infections Group. European Organisation for Research and Treatment of Cancer. (2002) (9)
- Evaluation of serum Mucorales PCR for the diagnosis of Mucormycoses: The MODIMUCOR prospective trial. (2022) (9)
- Final results of the efficacy and safety of rasburicase (recombinant urate oxydase) for the prevention and treatment of hyperuricemia in patients with aggressive lymphoma (GRAAL 1 study). (2002) (9)
- Etoposide, ifosfamide and methotrexate combination chemotherapy in patients with aggressive non‐hodgkin's lymphoma after failure of the LNH 84 regimen (2006) (9)
- [Rare opportunistic fungal diseases in patients with organ or bone marrow transplantation]. (1992) (9)
- Value of autologous bone marrow transplantation (ABMT) in 42 patients with follicular lymphomas responsive to conventional chemotherapy: a "France Autogreffe" study. (1996) (8)
- Idarubicin and high dose cytarabine: a new salvage treatment for refractory or relapsing non-Hodgkin's lymphoma. (1996) (8)
- Waldenström's macroglobulinemia harbors a unique proteome where Ku70 is severely underexpressed as compared with other B-lymphoproliferative disorders (2012) (8)
- Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. (1995) (8)
- The design of clinical trials that evaluate antifungal prophylaxis and combination therapy: introduction and overview. (2004) (8)
- Stimulation of B-Cell Lymphoproliferations with CpG-Oligonucleotide DSP30 Plus IL-2 Is More Effective than with TPA to Detect Clonal Abnormalities. (2008) (8)
- High dose melphalan and ABMT with or without abdominal radiotherapy as consolidation treatment for ovarian carcinoma in complete remission or with microscopic residual disease. (1991) (8)
- P980 Liposomal amphotericin B standard dose in combination with caspofungin versus liposomal amphotericin B high dose regimen for the treatment of invasive aspergillosis in immunocom-promised patients: randomised pilot study (Combistrat Trial) (2007) (8)
- Haemorrhagic and thrombotic diatheses in mouse models with thrombocytosis (2014) (8)
- [Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer]. (2000) (8)
- Malignant thymic lymphoblastic lymphoma and myasthenia gravis: an exceptional association. (1992) (7)
- Synergistic efficacy of recombinant human granulocyte colony-stimulating factor and amphotericin B against disseminated candidosis in non neutropenic mice (1996) (7)
- Systematic review and network meta-analysis of clinical outcomes associated with isavuconazole versus relevant comparators for patients with invasive aspergillosis (2018) (7)
- Executive Summary of the 2017 ESCMID -ECMM Guideline for the Diagnosis and Management of Aspergillus Disease (2018) (7)
- Successful treatment of visceral leishmaniasis with high-dose amphotericin B diluted in fat emulsion: a case report. (1996) (7)
- Comparative survival and cost of antifungal therapy: posaconazole versus standard antifungals in the treatment of refractory invasive aspergillosis (2010) (7)
- [Trichosporon capitatum septicemia in immunosuppressed patients]. (1990) (7)
- Validation by real-life data of the new radiological criteria of the revised and updated consensus definition for invasive fungal diseases. (2020) (7)
- Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt. (2006) (6)
- ESCMID Diagnostic and management guideline for Candida diseases 2012: Developing European guidelines in clinical microbiology and infectious diseases. (2012) (6)
- Neutrophils differentially attenuate immune response to Aspergillus infection through complement receptor 3 and induction of myeloperoxidase (2018) (6)
- Results of a Phase II Study of Pixantrone in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin’s Lymphoma. (2006) (6)
- Earlier diagnosis of angioinvasive pulmonary mold disease: is computed tomography pulmonary angiography a new step? (2012) (6)
- [Renal clear-cell adenocarcinoma and type B lymphomatous proliferation: a fortuitous association?]. (1999) (6)
- Systemic Antifungal Prophylaxis in Patients Hospitalized in Hematology Units in France: The AFHEM Cross-Sectional Observational Study (2018) (6)
- Effects of bacterial naso-oropharyngeal colonisation on acute graft-versus-host disease in patients undergoing allogeneic bone marrow transplantation. (1995) (6)
- Ventricular bigeminy associated with voriconazole, methadone and esomeprazole (2011) (6)
- Methylprednisolone‐induced immune thrombocytopenia (2020) (5)
- Managing the challenges of invasive fungal infections. (2006) (5)
- Factors associated with coinfections in invasive aspergillosis: a retrospective cohort study. (2021) (5)
- History and Outcome of Febrile Neutropenia Outside the Oncology Setting: A Retrospective Study of 76 Cases Related to Non-Chemotherapy Drugs (2017) (5)
- Assessment of high-priced systemic antifungal prescriptions. (2017) (5)
- Febrile pancytopenia as uncommon presentation of disseminated toxoplasmosis after BMT (2012) (5)
- CHOP-R (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, Rituximab) Compared to CPOP-R (Cyclophosphamide, Pixantrone, Vincristine, Prednisone, Rituxamib) in First-Line Therapy of Diffuse Large B Cell Lymphoma (DLBCL): An Interim Analysis. (2007) (5)
- [Capillary hyperpermeability syndrome of the face]. (2000) (5)
- Anti-pseudo-PCNA type 1 (anti-SG2NA) pattern: Track down Cancer, not SLE. (2016) (5)
- Micafungin prophylaxis in routine medical practice in adult and pediatric patients with hematological malignancy: a prospective, observational study in France. (2019) (5)
- Ruxolitinib Therapy in Myelofibrosis: Analysis of 241 Patients Treated in Compassionate Use (French “ATU” program) by the French Intergroup of Myeloproliferative Neoplasms (FIM). (2012) (5)
- Effect of pristinamycin on cyclosporin levels in bone marrow transplant recipients. (1989) (5)
- [Trichosporon capitatum septicemia. Apropos of 5 cases]. (1992) (5)
- Improving the outcome of invasive aspergillosis: new diagnostic tools and new therapeutic strategies. (2002) (5)
- Piperacillin and netilmicin combination therapy for febrile episodes in neutropenic patients (1990) (4)
- A phase I study of pixantrone (BBR 2778) in combination with cyclophosphamide, vincristine and prednisone in patients with relapsed aggressive non-Hodgkin's lymphoma. (2003) (4)
- Proceedings of Réanimation 2017, the French Intensive Care Society International Congress (2017) (4)
- Alternance of chemotherapy does not improve results in aggressive non-Hodgkin's lymphoma: A prospective randomized study on 884 patients LNH87 protocol group 3: A gela study (1996) (4)
- Etoposide, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen. (1992) (4)
- Cerebral mucormycosis: neuroimaging findings and histopathological correlation (2021) (4)
- A European prospective invasive mould disease audit (2014) (4)
- Hearing loss due to acute leukemia. (2000) (4)
- Alternating Chemotherapy Does Not Improve Results in Poor-prognosis Aggressive Lymphomas - Lnh87 Protocol Group-3 - a Gela Study (1993) (4)
- Invasive pulmonary aspergillosis treatment duration in haematology patients in Europe: An EFISG, IDWP‐EBMT, EORTC‐IDG and SEIFEM survey (2020) (4)
- [Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients]. (2014) (4)
- Impact of cytokines and growth factors in the antifungal armamentarium. (1995) (4)
- Pregnancy outcome in women with transfused beta-thalassemia in France (2021) (3)
- Incidental Discovery of a COVID-19 Infection on a Reevaluation FDG PET/CT in a Patient Treated for Hodgkin Lymphoma (2020) (3)
- Antifungal Stewardship in Hematology: Reflection of a Multidisciplinary Group of Experts. (2020) (3)
- Brain abscesses caused by Cladophialophora bantiana in a lung transplant patient: A case report and review of the literature (2017) (3)
- Clinical antifungal efficacy trials in invasive aspergillosis: Consensus standards for trial design and room for improvement. (2006) (3)
- Reply to Verweij et al (2007) (3)
- Mycobacterial infections in adults with haematological malignancies and haematopoietic stem cell transplants: guidelines from the 8th European Conference on Infections in Leukaemia. (2022) (3)
- CPOP-R Versus CHOP-R as First-line Therapy for Diffuse Large B-cell Lymphoma (DLBCL): A Phase 2, Randomized, Open-label, Multicenter Study (2011) (3)
- [Potential clinical impact of therapeutic education in patients treated with anticancer drugs]. (2011) (3)
- Bendamustine Versus Chlorambucil in Treatment-Naive B-CLL Patients. (2004) (3)
- Efficacy and safety of Rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Preliminary results of a multicenter, open label, phase II trial (M39037 TRIAL) (2002) (3)
- Prognostic factors in ovarian carcinoma in complete histologic remission at second-look surgery. (1999) (3)
- [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes]. (1994) (2)
- Temporal multiomic modeling reveals a B-cell receptor proliferative program in chronic lymphocytic leukemia (2021) (2)
- Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients (2016) (2)
- [Invasive aspergillosis in immunocompromised patients. An analysis of 57 patients]. (1992) (2)
- Supportive Efficacy Analyses for the Phase 3 Study of Temsirolimus Versus Investigator’s Choice Therapy for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma. (2008) (2)
- Rare oral metastasis from a probable large-cell neuroendocrine carcinoma of the lung (2016) (2)
- [Clinical and radiological aspects of mucormycosis]. (2013) (2)
- Preliminary Phase II Study Results of BBR2778 in Combination with Cyclophosphamide, Vincristine, and Prednisone in Patients with Relapsed Aggressive Non-Hodgkin’s Lymphoma. (2004) (2)
- Reply to Denning (2007) (2)
- Large deletions of the 5′ region of IKZF1 lead to haploinsufficiency in B‐cell precursor acute lymphoblastic leukaemia (2019) (2)
- Using routine blood parameters to anticipate clinical outcomes in invasive aspergillosis. (2020) (2)
- Mycograb for the treatment of invasive candidiasis. Authors' reply (2006) (2)
- Intraperitoneal mitoxantrone as consolidation treatment for stage III ovarian carcinoma: a pilot study. (1991) (2)
- [Diffuse digestive tract B-cell lymphoma manifesting as exudative enteropathy]. (1998) (2)
- Fatal Aspergillus fumigatus Myositis in an Immunocompetent Patient (2001) (2)
- [A cytological, immunophenotypical and cytogenetical study of 136 consecutive cases of B-cell chronic lymphoid hemopathies]. (2007) (2)
- Candida albicans vertebral osteomyelitis treated successfully with fluconazole (1997) (2)
- Prognostic Factors for Survival in Invasive Aspergillosis in Adult Oncohematological Patients. (2006) (2)
- Proteomic Analysis of Shed Membrane Microparticles from Malignant Lymphoid Cells: A New Tool for Membrane Proteins Studies. (2005) (2)
- Multimodality Diagnosis Approach of Cardiac Aspergillosis (2016) (2)
- Hospital Resource Utilization in Acute Invasive Aspergillosis (AIA) Patients (Pts) Treated with Voriconazole (VOR) or Amphotericin B (CAB). (2004) (2)
- Updated Efficacy and Safety, and Exploratory Ki-67 Results For The MCL-001 Study Of Lenalidomide In Mantle Cell Lymphoma Patients Who Relapsed Or Were Refractory To Bortezomib (2013) (2)
- P397 Influence of underlying conditions on disease presentation and diagnostic strategy during pulmonary mucormycosis: Anational study of 114 cases (2022) (2)
- Caspofungin (C) as First-Line Therapy of Invasive Aspergillosis (IA) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients: a Study of the EORTC Infectious Diseases Group (2008) (2)
- [Therapeutic aspects in the management of hairy cell leukemia]. (1999) (1)
- Mannose-Binding Lectin Deficiency - a Risk Factor for Invasive Aspergillosis in Immunocompromised Patients. (2008) (1)
- BCR-associated factors driving chronic lymphocytic leukemia cells proliferation ex vivo (2019) (1)
- [Treatment with a piperacillin and netilmicin combination of patients with agranulocytosis]. (1988) (1)
- Traitement du purpura thrombopnique idiopathique de l'adulte: propos d'une srie de 201 patients (1999) (1)
- Proteomic Analysis of Chronic Malignant B-Cell Derived Microparticles Reveals CD148 as a Potential Antigenic Marker for Mantle Cell Lymphoma Diagnosis. (2008) (1)
- The Contribution of CD148, CD180 and CD200 Combination in the Diagnosis of Chronic B-Cell Lymphoproliferative Disorders (2021) (1)
- Cerebral aspergillosis in the era of new antifungals: the CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS). (2021) (1)
- standard CHOP for poor-prognosis aggressive non-Hodgkin lymphoma Intensive conventional chemotherapy (ACVBP regimen) compared with (2009) (1)
- Amotosalen-inactivated fresh frozen plasma is comparable to solvent-detergent inactivated plasma to treat thrombotic thrombocytopenic purpura. (2019) (1)
- VP-16, ifosfamide, and methotrexate combination chemotherapy for aggressive non-Hodgkin's lymphomas after failure of the LNH 84 regimen (2004) (1)
- Invasive Pulmonary Aspergillosis (2023) (1)
- [Results of cisplatin-based polychemotherapy and analysis of prognostic factors in ovarian cancer. Apropos of 106 cases]. (1989) (1)
- Pharmacokinetic drug-drug interactions with methotrexate (2011) (1)
- Correspondence Mycograb for the Treatment of Invasive Candidiasis (2006) (1)
- [Acute myeloblastic leukemias and myelodysplasias: treatment with low doses of aracytine]. (1986) (1)
- Long term efficacy of rituximab in B-cell post transplantation lymphoproliferative disorders (B-PTLD): Update of the multicenter, open label, phase II trial (M39037 trial) (2006) (1)
- Multicentric Analyses of the CD148, CD180, and CD200 Combination for the Diagnosis of Mature B-Cell Neoplasm Using Flow Cytometry (2015) (1)
- [Management of febrile episodes in neutropenic patients]. (1998) (1)
- [New lipid formulations of amphotericin B. Review of the literature]. (2001) (1)
- Introduction to the forum report on advances in the design of antifungal clinical trials (2003) (1)
- Severe Neutropenia and Agranulocytosis Related to Antithyroid Drugs: A Study of 30 Cases Managed in A Single Reference Center (2020) (1)
- Bendamustine versus chlorambucil in treatment- naive patients with chronic lymphocytic leukemia: Updated results of an international phase III study (2009) (1)
- Correction for Cornu et al., “Evaluation of Mass Spectrometry-Based Detection of Panfungal Serum Disaccharide for Diagnosis of Invasive Fungal Infections: Results from a Collaborative Study Involving Six European Clinical Centers” (2019) (1)
- Liposomal Amphotericin B Trial Marred by Conclusions. Authors' reply (2007) (1)
- Hepatic Safety of Isavuconazole Compared with Voriconazole in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Complicated by Invasive Mold Disease – A Post-Hoc Analysis from the SECURE Study (2016) (1)
- PF679 REAL-WORLD SAFETY DATA FROM A NONINTERVENTIONAL LONG-TERM POSTAUTHORIZATION SAFETY STUDY OF RUXOLITINIB IN MYELOFIBROSIS (2019) (0)
- Review of lipid-amphotericin B formulations in the treatment of candidiasis and personnal experience (1996) (0)
- Diagnostic et prise en charge des aspergilloses invasives (2008) (0)
- Are There Specific Markers in Allografted Patients Blood Predicting GvHD (2008) (0)
- [Pseudotumoral pneumocystosis: one case and a review of the literature]. (1989) (0)
- [Treatment of aggressive primary lymphomas of the digestive system by intensive chemotherapy. Experience of the Study Group on Lymphomas in Adults with the LNH-84 protocol]. (1992) (0)
- Recombinant alpha-interferon plus vinblastine in metastatic renal-cell cancer: analysis of response and survival in 58 evaluable patients. (1990) (0)
- Bone-marrow Transplantation Prolongs Survival After Relapse in Lymphoma Patients - Long-term Follow-up (1993) (0)
- A Phase I/II Study of Dose-Escalated Ifosfamide plus Carboplatin Combination for Advanced Ovarian Carcinoma (1999) (0)
- Zygomycosis After Allogeneic Hematopoietic Stem Cell Transplantation: A French Multicenter Cohort Study (2003-2008) (2010) (0)
- [Inhibition of poly-ADP-ribose synthetase, a new approach in research on the reduction of cellular proliferation]. (1983) (0)
- Recombinant Interferon Alpha Plus Vinblastine in Metastatic Renal Cell Cancer: Updated Results (1991) (0)
- [Post-therapy surveillance in non-Hodgkin's lymphomas]. (2002) (0)
- Halo Sign and Improved Outcome. Authors' reply (2007) (0)
- Idiopathic Thrombocytopenic Purpura and Radiotherapy: A Case Report and Review of the Literature (2020) (0)
- Systemic antifungal strategies in allogeneic hematopoietic stem cell recipients hospitalized in french hematology units: a post-hoc analysis of the cross-sectional observational AFHEM study (2022) (0)
- Flow Cytometry Study of CD148, a Tyrosine Phosphatase Receptor, in 184 Chronic B Cell Malignancies, Reveals a High Expression in Mantle Cell and Marginal Zone Lymphomas. (2009) (0)
- O21 Intravascular lymphoma with hemophagocytic syndrome and bone marrow involvement: an Asian variant in Europa? (2003) (0)
- Successful Treatment af a Hairy Cell Leukemia (HCL) with Pentostatin in a Cardiac Transplant Recipient. (2004) (0)
- [Lipid formulations of amphotericin B in the management of invasive fungal infections]. (2006) (0)
- CASE REPORT Candida catenulata Fungemia in a Cancer Patient (1999) (0)
- List of Reviewers 2007 (2007) (0)
- Antifungal Therapy in Patients with Hematological Malignancies (2011) (0)
- Germline Mutations Occurring Outside the Negatively Charged Amino Acid Stretches of the Exon 9 of Calr : A Predisposition to Hematological Malignancies? (2017) (0)
- Anticorps anti-pseudo-PCNA : description clinique et biologique d’une cohorte de 96 patients (2014) (0)
- Reply to Wolf et al. (2007) (0)
- Posttransplant Malignant Lymphomas (PTL) Treated with Doxorubicin-Based Chemotherapy (1995) (0)
- EFFICACY AND SAFETY OF RITUXIMAB IN B-CELL POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: RESULTS OF A PROSPECTIVE MULTICENTRE PHASE II STUDY Running head: Rituximab in PTLD (2017) (0)
- Original Isavuconazole for the treatment of patients with invasive fungal diseases involving the central nervous system (2020) (0)
- Section 2: Technical Aspects (2012) (0)
- phase 2 study lymphoproliferative disorders: results of a prospective multicenter Efficacy and safety of rituximab in B-cell post-transplantation (2011) (0)
- Comparative Effectiveness of Plasma Prepared with Pathogen Inactivation (INTERCEPT) and Quarantine Plasma (PFCS) for Therapeutic Plasma Exchange of Patients with Thrombotic Thrombocytopenic Purpura (2012) (0)
- Gut Aspergillus Infections in Leukemia and Stem Cell Transplant Patients: A Rare and Unrecognized Disease (2009) (0)
- Interest of the CD148, CD180 and CD200 Combination in Flow Cytometry Analyses for Mature B-Cell Neoplasms Diagnosis (2014) (0)
- Strong Cell Surface Expression of the Toll-Like Receptor Homolog CD180 Identifies Circulating Cells of Marginal Zone Lymphoma From Other B-Cell Malignancies (2012) (0)
- Author and Subject Index (1999) (0)
- Amphotericin B colloidal dispersion : an advance in antifungal therapy (1999) (0)
- ZAP-70 Expression in Non Tumoral B Cells: Role in B Tolerance Breakdown? (2018) (0)
- [Erratum to "Medication adverse events: Impact of pharmaceutical consultations during the hospitalization of patients" [Ann. Pharm. Fr. 72 (2014) 440-450].] (2015) (0)
- A Core Proliferative Program Induced By B-Cell Receptor Stimulation in Chronic Lymphocytic Leukemia Cells (2019) (0)
- [18F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for early evaluation of treatment efficacy in advanced non-Hodgkin lymphoma of uterine corpus: a case report. (2007) (0)
- Management of Acute Myeloid Leukemia (AML) in First Relapse: Retrospective Analysis about 101 Adults Cases Receiving Homogeneous First-Line Therapy. Impact of Prognostic Factors and Treatment. (2004) (0)
- Multi-omics dataset to decipher the complexity of drug resistance in diffuse large B-cell lymphoma (2019) (0)
- Review Article Function of Ikaros as a tumor suppressor in B cell acute lymphoblastic leukemia (2013) (0)
- Safety and efficacy of Intralipid emulsions of amphotericin B J A ntimicrob Chemother 1997 ; 40 : 137 – 139 (2017) (0)
- An atypical cause of dyspnea. (2019) (0)
- Anticorps anti-pseudo-PCNA de type 1 (anti-SG2NA) : cherchez un cancer, pas le lupus ☆ (2017) (0)
- Cost-effectiveness of posaconazole in the prophylaxis of invasive fungal infections in the French setting (2008) (0)
- Comparative Effectiveness and Safety Of Pathogen Inactivated (Amotosalen-UVA) and Conventional Plasma For Treatment Of Auto-Immmune Thrombotic Thrombocytopenic Purpura (TTP): A 15-Year Retrospective Review (2013) (0)
- 1172. Mucormycosis Treated with Isavuconazole: A matched-Pair Analysis from the FungiScope® Registry (2020) (0)
- TEP/TDM au 18F-FDG dans la prise en charge des patients immunodéprimés atteints d’infection fongique invasive : analyse rétrospective de 51 patients (2018) (0)
- Poly(ADP‐ribose)polymerase inhibitors‐associated myeloid neoplasms: a retrospective study from the French Network of Pharmacovigilance centres (2021) (0)
- Can combination salvage therapy for invasive aspergillosis improve patient outcome? (2005) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Raoul Herbrecht?
Raoul Herbrecht is affiliated with the following schools:
